Tabulated responses (N = 36 patients)
| Type of response . | N . | % . |
|---|---|---|
| Hematologic response | ||
| Complete response | 8 | 22 |
| Very good partial response | 2 | 6 |
| Partial response | 1 | 3 |
| No response | 15 | 42 |
| Not assessed or assessable | 10 | 28 |
| VEGF response | ||
| Complete response | 4 | 11 |
| Partial response | 1 | 3 |
| No response | 5 | 14 |
| Not assessed or assessable | 26 | 72 |
| FDG-PET response | ||
| Complete response | 4 | 11 |
| Partial response | 4 | 11 |
| No response | 5 | 14 |
| Not assessed or assessable | 23 | 64 |
| Clinical response | ||
| Improved | 17 | 47 |
| Mixed | 10 | 28 |
| Stable | 2 | 6 |
| Progressed | 7 | 19 |
| Type of response . | N . | % . |
|---|---|---|
| Hematologic response | ||
| Complete response | 8 | 22 |
| Very good partial response | 2 | 6 |
| Partial response | 1 | 3 |
| No response | 15 | 42 |
| Not assessed or assessable | 10 | 28 |
| VEGF response | ||
| Complete response | 4 | 11 |
| Partial response | 1 | 3 |
| No response | 5 | 14 |
| Not assessed or assessable | 26 | 72 |
| FDG-PET response | ||
| Complete response | 4 | 11 |
| Partial response | 4 | 11 |
| No response | 5 | 14 |
| Not assessed or assessable | 23 | 64 |
| Clinical response | ||
| Improved | 17 | 47 |
| Mixed | 10 | 28 |
| Stable | 2 | 6 |
| Progressed | 7 | 19 |